Pure Global

Boyi's first generation blood glucose measurement system - Taiwan Registration cf78eefd7ef5939a8fe540a11298e748

Access comprehensive regulatory information for Boyi's first generation blood glucose measurement system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number cf78eefd7ef5939a8fe540a11298e748 and manufactured by EPS BIO TECHNOLOGY CORP.. The authorized representative in Taiwan is EPS BIO TECHNOLOGY CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
cf78eefd7ef5939a8fe540a11298e748
Registration Details
Taiwan FDA Registration: cf78eefd7ef5939a8fe540a11298e748
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Boyi's first generation blood glucose measurement system
TW: ๅšไพ็ฌฌไธ€ไปฃ่ก€็ณ–้‡ๆธฌ็ณป็ตฑ
Risk Class 2
Cancelled

Registration Details

cf78eefd7ef5939a8fe540a11298e748

Company Information

Taiwan, Province of China

Product Details

It is used for in vitro measurement of blood glucose content in fresh microvascular whole blood samples and is not suitable for neonatal testing.

A Clinical chemistry and clinical toxicology

A.1345 Glucose Test System

Domestic

Dates and Status

May 20, 2013

Sep 23, 2021

Sep 08, 2023

Cancellation Information

Logged out

ๆœชๅฑ•ๅปถ่€Œ้€พๆœŸ่€